A Deep Dive Into the Role of PARP Inhibitors: Equipping Healthcare Professionals With the Necessary Tools for Improving Care in Ovarian Cancer

Download All
Read this commentary from Colleen Bohnenkamp, PharmD, BCOP, BCPS, and Dane Fritzsche, PharmD, BCOP, on frequently asked questions regarding pharmacists’ use of PARP inhibitors for ovarian cancer.
Colleen Bohnenkamp, PharmD, BCOP, BCPS
Dane Fritzsche, PharmD, BCOP

ClinicalThought

Read this commentary from Colleen Bohnenkamp, PharmD, BCOP, BCPS, and Dane Fritzsche, PharmD, BCOP, on frequently asked questions regarding pharmacists’ use of PARP inhibitors for ovarian cancer.

Colleen Bohnenkamp, PharmD, BCOP, BCPS Dane Fritzsche, PharmD, BCOP Released: December 7, 2021
Provided by ProCE, LLC, a Clinical Education Alliance Company

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Coproduced by ProCE and the NASP Center for Specialty Pharmacy Education (CSPE).
This activity is supported by educational grants from
GlaxoSmithKline
AbbVie Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings